BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 2214638)

  • 1. [Hemostatic disorders in patients with Schoenlein-Henoch syndrome].
    Mishkova R; Kudeva K; Petrova E
    Klin Med (Mosk); 1990 Jun; 68(6):47-9. PubMed ID: 2214638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathophysiology and clinical aspects of fibrinolysis and inhibition of coagulation. Experimental and clinical studies with special reference to women on oral contraceptives and selected groups of thrombosis prone patients.
    Jespersen J
    Dan Med Bull; 1988 Feb; 35(1):1-33. PubMed ID: 3277796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Platelet aggregation and Schoenlein-Henoch syndrome].
    Sardella M; Arturi L; Caroni G; Maiullari E; Lange MM; Corsi CM
    Minerva Pediatr; 1983 Nov; 35(22):1085-96. PubMed ID: 6672596
    [No Abstract]   [Full Text] [Related]  

  • 4. Lupus anticoagulant and thrombosis following Henoch-Schonlein purpura.
    Abend NS; Licht DJ; Spencer CH
    Pediatr Neurol; 2007 May; 36(5):345-7. PubMed ID: 17509470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood coagulation abnormalities in the Schönlein-Henoch syndrome in adults.
    Boros G; Gofman L; Sámsik J; Nagy J; Hámori A; Deák G
    Acta Med Acad Sci Hung; 1979; 36(2):151-66. PubMed ID: 397710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laboratory signs of activated coagulation are common in Henoch-Schönlein purpura.
    Brendel-Müller K; Hahn A; Schneppenheim R; Santer R
    Pediatr Nephrol; 2001 Dec; 16(12):1084-8. PubMed ID: 11793106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study of coagulation and fibrinolysis in 131 cases of recurrent deep vein thrombosis].
    Conard J; Veuillet-Duval A; Horellou MH; Samama M
    Nouv Rev Fr Hematol (1978); 1982; 24(3):205-9. PubMed ID: 7133990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New data on the mechanisms and methods of eliminating hemostatic disorders in hemorrhagic vasculitis in children].
    Barkagan LZ; Anmut SIa
    Pediatriia; 1980 Jul; (7):43-6. PubMed ID: 7413345
    [No Abstract]   [Full Text] [Related]  

  • 9. [Thrombosis induced by homocysteine does not depend on platelet aggregation or heparin cofactor's antithrombin activity].
    Zhang L; Zhang G
    Hunan Yi Ke Da Xue Xue Bao; 1999; 24(4):309-12, 340. PubMed ID: 12080632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Rheological changes in the blood and disseminated intravascular coagulation (DIC) in systemic vasculitis].
    Kuznetsov IuA
    Ter Arkh; 1985; 57(8):139-43. PubMed ID: 2866596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating IgA producing cells in the differential diagnosis of Henoch-Schönlein purpura.
    Casanueva B; Rodriguez-Valverde V; Luceño A
    J Rheumatol; 1988 Aug; 15(8):1229-33. PubMed ID: 3184070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Signs of hypercoagulation and activation of fibrinolysis in patients with Wegeners's granulomatosis and Schoenlein-Genoch's purpura].
    Strizhakov LA; Chegaeva EP; Krivosheev OG; Semenkova EN; Baĭmuradova SM
    Klin Med (Mosk); 2012; 90(5):43-5. PubMed ID: 22993951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Favorable effects of epsilon-aminocaproic acid on the children with nephrotic syndrome and Schonlein-Henoch syndrome treated with corticosteroids].
    Prandota J; Panków-Prandota L; Rotter A; Kotecki L
    Pol Merkur Lekarski; 1996 Oct; 1(4):241-5. PubMed ID: 9156934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of low dose heparin in elective surgery on blood coagulation, fibrinolysis, platelet function, antithrombin III and antiplasmin.
    Kruse-Blinkenberg HO; Gormsen J
    Acta Chir Scand; 1980; 146(6):375-82. PubMed ID: 7008475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The changes and relation among platelet function, plasma heparin and anti-coagulation-III: activity in patients with hemorrhagic fever with renal syndrome].
    Wei L; Pan X; Yu Y; Lu Q
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Jun; 11(2):163-5. PubMed ID: 15619827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormally large von Willebrand factor multimers in Henoch-Schönlein purpura.
    Casonato A; Pontara E; Bertomoro A; Ossi E; Vincenti M; Girolami A; Borsatti A; Bertaglia G
    Am J Hematol; 1996 Jan; 51(1):7-11. PubMed ID: 8571941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Elevated level of Helicobacter pylori antibodies in Henoch-Schonlein purpura].
    Novák J; Csiki Z; Sebesi J; Takáts A; Demeter P; Sipka S
    Orv Hetil; 2003 Feb; 144(6):263-7. PubMed ID: 12666632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The prognostic value of factor XIII in Schönlein-Henoch purpura in childhood (author's transl)].
    Dalens B; Bezou MJ; Goumy P; Déméocq F; Menut G
    Arch Fr Pediatr; 1980 Feb; 37(2):99-101. PubMed ID: 7396652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased levels of plasma D-dimer in the course of Henoch-Schönlein purpura.
    Zajadacz B; Juszkiewicz A
    Wiad Lek; 2005; 58(9-10):581-3. PubMed ID: 16529076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of diffuse glomerulonephritis in adults with Schönlein-Henoch disease using a combination of anticoagulants, corticosteroids and immunosuppressants].
    Belovezhdov N
    Vutr Boles; 1986; 25(2):21-5. PubMed ID: 3716373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.